476 related articles for article (PubMed ID: 16442481)
1. Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer.
Navigante AH; Cerchietti LC; Castro MA; Lutteral MA; Cabalar ME
J Pain Symptom Manage; 2006 Jan; 31(1):38-47. PubMed ID: 16442481
[TBL] [Abstract][Full Text] [Related]
2. Midazolam as adjunct therapy to morphine to relieve dyspnea?
Sironi O; Sbanotto A; Banfi MG; Beltrami C
J Pain Symptom Manage; 2007 Mar; 33(3):233-4; author reply 234-6. PubMed ID: 17349490
[No Abstract] [Full Text] [Related]
3. Morphine versus midazolam as upfront therapy to control dyspnea perception in cancer patients while its underlying cause is sought or treated.
Navigante AH; Castro MA; Cerchietti LC
J Pain Symptom Manage; 2010 May; 39(5):820-30. PubMed ID: 20471543
[TBL] [Abstract][Full Text] [Related]
4. Effects of intravenous patient-controlled analgesia with buprenorphine and morphine alone and in combination during the first 12 postoperative hours: a randomized, double-blind, four-arm trial in adults undergoing abdominal surgery.
Oifa S; Sydoruk T; White I; Ekstein MP; Marouani N; Chazan S; Skornick Y; Weinbroum AA
Clin Ther; 2009 Mar; 31(3):527-41. PubMed ID: 19393843
[TBL] [Abstract][Full Text] [Related]
5. Morphine for dyspnea control in terminal cancer patients: is it appropriate in Taiwan?
Hu WY; Chiu TY; Cheng SY; Chen CY
J Pain Symptom Manage; 2004 Oct; 28(4):356-63. PubMed ID: 15471653
[TBL] [Abstract][Full Text] [Related]
6. The use of midazolam and haloperidol in cancer patients at the end of life.
Radha Krishna LK; Poulose VJ; Goh C
Singapore Med J; 2012 Jan; 53(1):62-6. PubMed ID: 22252186
[TBL] [Abstract][Full Text] [Related]
7. A phase III randomized, double-blind, placebo-controlled study evaluating dextromethorphan plus slow-release morphine for chronic cancer pain relief in terminally ill patients.
Dudgeon DJ; Bruera E; Gagnon B; Watanabe SM; Allan SJ; Warr DG; MacDonald SM; Savage C; Tu D; Pater JL
J Pain Symptom Manage; 2007 Apr; 33(4):365-71. PubMed ID: 17397698
[TBL] [Abstract][Full Text] [Related]
8. Psychotropic drugs for terminally ill patients with respiratory disease.
Kanemoto K; Satoh H; Kagohashi K; Kurishima K; Ishikawa H; Ohtsuka M
Tuberk Toraks; 2007; 55(1):5-10. PubMed ID: 17401788
[TBL] [Abstract][Full Text] [Related]
9. "Palliative" and not "terminal" sedation.
Koh YH; Lee OK; Wu HY
J Pain Symptom Manage; 2009 Apr; 37(4):e6-8. PubMed ID: 19345295
[No Abstract] [Full Text] [Related]
10. Nebulized versus subcutaneous morphine for patients with cancer dyspnea: a preliminary study.
Bruera E; Sala R; Spruyt O; Palmer JL; Zhang T; Willey J
J Pain Symptom Manage; 2005 Jun; 29(6):613-8. PubMed ID: 15963870
[TBL] [Abstract][Full Text] [Related]
11. [Symptomatic treatment of dyspnoea in patients receiving palliative care: nasal delivery of oxygen compared with opioid administration].
Clemens KE; Klaschik E
Dtsch Med Wochenschr; 2007 Sep; 132(38):1939-43. PubMed ID: 17853348
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: a randomized, double-blind, active- and placebo-controlled, parallel-group trial.
Aqua K; Gimbel JS; Singla N; Ma T; Ahdieh H; Kerwin R
Clin Ther; 2007 Jun; 29(6):1000-12. PubMed ID: 17692717
[TBL] [Abstract][Full Text] [Related]
13. Comparison of opioid requirements and analgesic response in opioid-tolerant versus opioid-naïve patients after total knee arthroplasty.
Patanwala AE; Jarzyna DL; Miller MD; Erstad BL
Pharmacotherapy; 2008 Dec; 28(12):1453-60. PubMed ID: 19025426
[TBL] [Abstract][Full Text] [Related]
14. Dextropropoxyphene versus morphine in opioid-naive cancer patients with pain.
Mercadante S; Salvaggio L; Dardanoni G; Agnello A; Garofalo S
J Pain Symptom Manage; 1998 Feb; 15(2):76-81. PubMed ID: 9494305
[TBL] [Abstract][Full Text] [Related]
15. Morphine-methadone opioid rotation in cancer patients: analysis of dose ratio predicting factors.
Benítez-Rosario MA; Salinas-Martín A; Aguirre-Jaime A; Pérez-Méndez L; Feria M
J Pain Symptom Manage; 2009 Jun; 37(6):1061-8. PubMed ID: 19171458
[TBL] [Abstract][Full Text] [Related]
16. Symptomatic therapy of dyspnea with strong opioids and its effect on ventilation in palliative care patients.
Clemens KE; Klaschik E
J Pain Symptom Manage; 2007 Apr; 33(4):473-81. PubMed ID: 17397708
[TBL] [Abstract][Full Text] [Related]
17. Safety and effectiveness of intravenous morphine for episodic breakthrough pain in patients receiving transdermal buprenorphine.
Mercadante S; Villari P; Ferrera P; Porzio G; Aielli F; Verna L; Casuccio A
J Pain Symptom Manage; 2006 Aug; 32(2):175-9. PubMed ID: 16877185
[TBL] [Abstract][Full Text] [Related]
18. Normal-release oral morphine starting dose in cancer patients with pain.
Ripamonti CI; Campa T; Fagnoni E; Brunelli C; Luzzani M; Maltoni M; De Conno F;
Clin J Pain; 2009 Jun; 25(5):386-90. PubMed ID: 19454871
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety profile of a single dose of hydromorphone compared with morphine in older adults with acute, severe pain: a prospective, randomized, double-blind clinical trial.
Chang AK; Bijur PE; Baccelieri A; Gallagher EJ
Am J Geriatr Pharmacother; 2009 Feb; 7(1):1-10. PubMed ID: 19281935
[TBL] [Abstract][Full Text] [Related]
20. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
